Tennessee 2023-2024 Regular Session

Tennessee Senate Bill SJR0044

Introduced
1/20/23  
Engrossed
2/27/23  
Refer
3/2/23  
Refer
3/14/23  
Refer
3/22/23  
Enrolled
4/4/23  

Caption

A RESOLUTION relative to improving the care of atherosclerotic cardiovascular disease.

Impact

The resolution urges state agencies to expand comprehensive cardiovascular screening programs. These programs are intended to facilitate earlier identification of patients at risk of cardiovascular events, thereby potentially reducing the incidence of ASCVD-related deaths and complications. Furthermore, it advocates for collaboration with federal and national agencies to enhance cardiovascular care and calls for an update to the state’s cardiovascular plan, aiming to accelerate quality improvements in diagnosis, treatment, and monitoring of patients. By implementing these measures, the resolution seeks to alleviate the burden of ASCVD on the healthcare system and improve overall public health outcomes in Tennessee.

Summary

SJR0044 is a Senate Joint Resolution aimed at improving the care and management of atherosclerotic cardiovascular disease (ASCVD) in Tennessee. The resolution highlights the significant impact of cardiovascular disease, which is the leading cause of death in the United States, and underscores the importance of addressing the high prevalence of ASCVD, particularly in Tennessee where substantial medical costs and a projection of escalating numbers are at stake. It acknowledges the alarming rates of high low-density lipoprotein cholesterol (LDL-C) among adults, which is a contributing factor to ASCVD, and calls for action to better manage these health risks.

Contention

While the resolution has garnered support due to its public health focus, some may argue about the feasibility of implementing widespread screening programs amid existing healthcare constraints. Critics could also point to the broad scope of collaboration required with federal entities and the challenge of sustaining funding for such initiatives. Additionally, the resolution's advocacy for policy creation to address the rising deaths from ASCVD signals a need for careful consideration of existing healthcare policies and potential legislative adjustments, which could become points of debate among lawmakers and constituents alike.

Companion Bills

No companion bills found.

Previously Filed As

TN S1964

Resolutions to improve the care of atherosclerotic cardiovascular disease

TN H3543

Resolutions to improve the care of atherosclerotic cardiovascular disease

TN ACR67

Atherosclerotic cardiovascular disease (ASCVD).

TN SR372

Atherosclerotic Cardiovascular Disease; improvement of care; support

TN H8109

House Resolution Supporting Improvements In The Care Of Atherosclerotic Cardiovascular Disease

TN S2890

Senate Resolution Supporting Improvements In The Care Of Atherosclerotic Cardiovascular Disease

TN HR336

Supporting the improvement of the care of atherosclerotic cardiovascular disease; commend

TN SR412

Atherosclerotic Cardiovascular Disease; support the improvement

TN SR56

Designating the month of February 2023 as "Atherosclerotic Cardiovascular Disease Month" in Pennsylvania.

TN HR171

Designating the month of June 2023 as "Atherosclerotic Cardiovascular Disease Month" in Pennsylvania.

Similar Bills

No similar bills found.